Global Pharmacogenomics (PGx) Market 2020 by Company, Type and Application, Forecast to 2025

Report ID: 36456 | Publish Date: May, 2020 | Pages: 156 | Format : PDF

Market Overview

The global Pharmacogenomics (PGx) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Pharmacogenomics (PGx) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation

Pharmacogenomics (PGx) market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for revenue by Type and Application. This analysis can help you expand your business by targeting qualified niche markets.

Breakdown by Type, Pharmacogenomics (PGx) market has been segmented into Polymerase Chain Reaction (PCR), Microarray, Sequencing, Other, etc.

Breakdown by Application, Pharmacogenomics (PGx) has been segmented into Cardiovascular Diseases (CVD), Central Nervous System (CNS), Cancer/Oncology, Infectious Diseases, Other, etc.

Regions and Countries Level Analysis

Regional analysis is another highly comprehensive part of the research and analysis study of the global Pharmacogenomics (PGx) market presented in the report. This section sheds light on the sales growth of different regional and country-level Pharmacogenomics (PGx) markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Pharmacogenomics (PGx) market.

For China, this report analyses the China market by players, Type and Application, for the period 2015-2025.

Competitive Landscape and Pharmacogenomics (PGx) Market Share Analysis

Pharmacogenomics (PGx) competitive landscape provides details by vendors, including company overview, company total revenue, market potential, global presence, Pharmacogenomics (PGx) revenue generated, market share, headquarters, SWOT analysis, product launch. For the period 2015-2020, this study provides the Pharmacogenomics (PGx) revenue and market share for each player covered in this report.

The major players covered in Pharmacogenomics (PGx) are: Abbott Laboratories, Myriad Genetics, Inc., Astrazeneca, Affymetrix, Inc., Laboratory Corporation of America Holdings, Assurex Health, Inc, Pfizer, Inc, Illumina, Inc., GeneDX, Pathway Genomics, Transgenomic, Inc., Qiagen, Inc., Thermo Fisher Scientific, Rocheg, Teva Pharmaceutical Industries Ltd., etc. Among other players domestic and global, Pharmacogenomics (PGx) market share data is available for global, North America, Europe, Asia, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Market segment by players, this report covers

    Abbott Laboratories

    Myriad Genetics, Inc.

    Astrazeneca

    Affymetrix, Inc.

    Laboratory Corporation of America Holdings

    Assurex Health, Inc

    Pfizer, Inc

    Illumina, Inc.

    GeneDX

    Pathway Genomics

    Transgenomic, Inc.

    Qiagen, Inc.

    Thermo Fisher Scientific

    Rocheg

    Teva Pharmaceutical Industries Ltd.

Market segment by regions, regional analysis covers

    North America (United States, Canada and Mexico)

    Europe (Germany, France, UK, Russia and Italy)

    Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)

    South America (Brazil, Argentina)

    MENA (Saudi Arabia, UAE, Turkey and South Africa)

Market segment by Type, covers:

    Polymerase Chain Reaction (PCR)

    Microarray

    Sequencing

    Other

Market segment by Application, can be divided into

    Cardiovascular Diseases (CVD)

    Central Nervous System (CNS)

    Cancer/Oncology

    Infectious Diseases

    Other


Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

    1.1 Product Overview and Scope of Pharmacogenomics (PGx)

    1.2 Classification of Pharmacogenomics (PGx) by Type

        1.2.1 Overview: Global Pharmacogenomics (PGx) Revenue by Type: 2015 Versus 2019 Versus 2025

        1.2.2 Global Pharmacogenomics (PGx) Revenue Market Share by Type in 2019

        1.2.3 Polymerase Chain Reaction (PCR)

        1.2.4 Microarray

        1.2.5 Sequencing

        1.2.6 Other

    1.3 Global Pharmacogenomics (PGx) Market by Application

        1.3.1 Overview: Global Pharmacogenomics (PGx) Revenue by Application: 2015 Versus 2019 Versus 2025

        1.3.2 Cardiovascular Diseases (CVD)

        1.3.3 Central Nervous System (CNS)

        1.3.4 Cancer/Oncology

        1.3.5 Infectious Diseases

        1.3.6 Other

    1.4 Global Pharmacogenomics (PGx) Market Size and Forecast (2015-2025)

    1.5 Global Pharmacogenomics (PGx) Market Size by Regions: 2015 VS 2019 VS 2025

    1.6 Global Pharmacogenomics (PGx) Market Size by Regions (2015-2020)

    1.7 Global Pharmacogenomics (PGx) Market Size and Forecast by Regions (2020-2025)

        1.7.1 North America Pharmacogenomics (PGx) Status and Prospect (2015-2025)

        1.7.2 Europe Pharmacogenomics (PGx) Status and Prospect (2015-2025)

        1.7.3 Asia Pharmacogenomics (PGx) Status and Prospect (2015-2025)

        1.7.4 South America Pharmacogenomics (PGx) Status and Prospect (2015-2025)

        1.7.5 Middle East & Africa Pharmacogenomics (PGx) Status and Prospect (2015-2025)

2 Company Profiles

    2.1 Abbott Laboratories

        2.1.1 Abbott Laboratories Details

        2.1.2 Abbott Laboratories Major Business and Total Revenue (Financial Highlights) Analysis

        2.1.3 Abbott Laboratories SWOT Analysis

        2.1.4 Abbott Laboratories Product and Services

        2.1.5 Abbott Laboratories Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2018-2019)

    2.2 Myriad Genetics, Inc.

        2.2.1 Myriad Genetics, Inc. Details

        2.2.2 Myriad Genetics, Inc. Major Business and Total Revenue (Financial Highlights) Analysis

        2.2.3 Myriad Genetics, Inc. SWOT Analysis

        2.2.4 Myriad Genetics, Inc. Product and Services

        2.2.5 Myriad Genetics, Inc. Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2018-2019)

    2.3 Astrazeneca

        2.3.1 Astrazeneca Details

        2.3.2 Astrazeneca Major Business and Total Revenue (Financial Highlights) Analysis

        2.3.3 Astrazeneca SWOT Analysis

        2.3.4 Astrazeneca Product and Services

        2.3.5 Astrazeneca Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2018-2019)

    2.4 Affymetrix, Inc.

        2.4.1 Affymetrix, Inc. Details

        2.4.2 Affymetrix, Inc. Major Business and Total Revenue (Financial Highlights) Analysis

        2.4.3 Affymetrix, Inc. SWOT Analysis

        2.4.4 Affymetrix, Inc. Product and Services

        2.4.5 Affymetrix, Inc. Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2018-2019)

    2.5 Laboratory Corporation of America Holdings

        2.5.1 Laboratory Corporation of America Holdings Details

        2.5.2 Laboratory Corporation of America Holdings Major Business and Total Revenue (Financial Highlights) Analysis

        2.5.3 Laboratory Corporation of America Holdings SWOT Analysis

        2.5.4 Laboratory Corporation of America Holdings Product and Services

        2.5.5 Laboratory Corporation of America Holdings Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2018-2019)

    2.6 Assurex Health, Inc

        2.6.1 Assurex Health, Inc Details

        2.6.2 Assurex Health, Inc Major Business and Total Revenue (Financial Highlights) Analysis

        2.6.3 Assurex Health, Inc SWOT Analysis

        2.6.4 Assurex Health, Inc Product and Services

        2.6.5 Assurex Health, Inc Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2018-2019)

    2.7 Pfizer, Inc

        2.7.1 Pfizer, Inc Details

        2.7.2 Pfizer, Inc Major Business and Total Revenue (Financial Highlights) Analysis

        2.7.3 Pfizer, Inc SWOT Analysis

        2.7.4 Pfizer, Inc Product and Services

        2.7.5 Pfizer, Inc Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2018-2019)

    2.8 Illumina, Inc.

        2.8.1 Illumina, Inc. Details

        2.8.2 Illumina, Inc. Major Business and Total Revenue (Financial Highlights) Analysis

        2.8.3 Illumina, Inc. SWOT Analysis

        2.8.4 Illumina, Inc. Product and Services

        2.8.5 Illumina, Inc. Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2018-2019)

    2.9 GeneDX

        2.9.1 GeneDX Details

        2.9.2 GeneDX Major Business and Total Revenue (Financial Highlights) Analysis

        2.9.3 GeneDX SWOT Analysis

        2.9.4 GeneDX Product and Services

        2.9.5 GeneDX Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2018-2019)

    2.10 Pathway Genomics

        2.10.1 Pathway Genomics Details

        2.10.2 Pathway Genomics Major Business and Total Revenue (Financial Highlights) Analysis

        2.10.3 Pathway Genomics SWOT Analysis

        2.10.4 Pathway Genomics Product and Services

        2.10.5 Pathway Genomics Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2018-2019)

    2.11 Transgenomic, Inc.

        2.11.1 Transgenomic, Inc. Details

        2.11.2 Transgenomic, Inc. Major Business and Total Revenue (Financial Highlights) Analysis

        2.11.3 Transgenomic, Inc. SWOT Analysis

        2.11.4 Transgenomic, Inc. Product and Services

        2.11.5 Transgenomic, Inc. Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2018-2019)

    2.12 Qiagen, Inc.

        2.12.1 Qiagen, Inc. Details

        2.12.2 Qiagen, Inc. Major Business and Total Revenue (Financial Highlights) Analysis

        2.12.3 Qiagen, Inc. SWOT Analysis

        2.12.4 Qiagen, Inc. Product and Services

        2.12.5 Qiagen, Inc. Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2018-2019)

    2.13 Thermo Fisher Scientific

        2.13.1 Thermo Fisher Scientific Details

        2.13.2 Thermo Fisher Scientific Major Business and Total Revenue (Financial Highlights) Analysis

        2.13.3 Thermo Fisher Scientific SWOT Analysis

        2.13.4 Thermo Fisher Scientific Product and Services

        2.13.5 Thermo Fisher Scientific Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2018-2019)

    2.14 Rocheg

        2.14.1 Rocheg Details

        2.14.2 Rocheg Major Business and Total Revenue (Financial Highlights) Analysis

        2.14.3 Rocheg SWOT Analysis

        2.14.4 Rocheg Product and Services

        2.14.5 Rocheg Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2018-2019)

    2.15 Teva Pharmaceutical Industries Ltd.

        2.15.1 Teva Pharmaceutical Industries Ltd. Details

        2.15.2 Teva Pharmaceutical Industries Ltd. Major Business and Total Revenue (Financial Highlights) Analysis

        2.15.3 Teva Pharmaceutical Industries Ltd. SWOT Analysis

        2.15.4 Teva Pharmaceutical Industries Ltd. Product and Services

        2.15.5 Teva Pharmaceutical Industries Ltd. Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2018-2019)

3 Market Competition, by Players

    3.1 Global Pharmacogenomics (PGx) Market Size by Players (2015-2020)

    3.2 China Pharmacogenomics (PGx) Market Size by Players (2015-2020)

    3.3 Market Concentration Rate

        3.3.1 Top 5 Pharmacogenomics (PGx) Players Market Share

        3.3.2 Top 10 Pharmacogenomics (PGx) Players Market Share

4 North America Market Size and Forecast by Countries

    4.1 North America Pharmacogenomics (PGx) Market Size by Countries (2015-2020)

    4.2 North America Pharmacogenomics (PGx) Market Size and Forecast by Countries (2015-2026)

    4.3 United States Pharmacogenomics (PGx) Market Size and Forecast (2015-2025)

    4.4 Canada Pharmacogenomics (PGx) Market Size and Forecast (2015-2025)

    4.5 Mexico Pharmacogenomics (PGx) Market Size and Forecast (2015-2025)

5 Europe Market Size and Forecast by Countries

    5.1 Europe Pharmacogenomics (PGx) Market Size by Countries (2015-2020)

    5.2 Europe Pharmacogenomics (PGx) Market Size and Forecast by Countries (2015-2026)

    5.3 Germany Pharmacogenomics (PGx) Market Size and Forecast (2015-2025)

    5.4 France Pharmacogenomics (PGx) Market Size and Forecast (2015-2025)

    5.5 UK Pharmacogenomics (PGx) Market Size and Forecast (2015-2025)

    5.6 Russia Pharmacogenomics (PGx) Market Size and Forecast (2015-2025)

    5.7 Italy Pharmacogenomics (PGx) Market Size and Forecast (2015-2025)

6 Asia-Pacific Market Size and Forecast by Countries

    6.1 Asia-Pacific Pharmacogenomics (PGx) Market Size by Regions (2015-2020)

    6.2 Asia-Pacific Pharmacogenomics (PGx) Market Size and Forecast by Regions (2015-2026)

    6.3 China Pharmacogenomics (PGx) Market Size and Forecast (2015-2025)

    6.4 Japan Pharmacogenomics (PGx) Market Size and Forecast (2015-2025)

    6.5 Korea Pharmacogenomics (PGx) Market Size and Forecast (2015-2025)

    6.6 India Pharmacogenomics (PGx) Market Size and Forecast (2015-2025)

    6.7 Southeast Asia Pharmacogenomics (PGx) Market Size and Forecast (2015-2025)

7 South America Market Size and Forecast by Countries

    7.1 South America Pharmacogenomics (PGx) Market Size by Countries (2015-2020)

    7.2 South America Pharmacogenomics (PGx) Market Size and Forecast by Countries (2015-2026)

    7.3 Brazil Pharmacogenomics (PGx) Market Size and Forecast (2015-2025)

    7.4 Argentina Pharmacogenomics (PGx) Market Size and Forecast (2015-2025)

8 Middle East & Africa Market Size and Forecast by Countries

    8.1 Middle East & Africa Pharmacogenomics (PGx) Revenue by Regions (2015-2020)

    8.2 Middle East & Africa Pharmacogenomics (PGx) Market Size and Forecast by Countries (2015-2026)

    8.3 Saudi Arabia Pharmacogenomics (PGx) Market Size and Forecast (2015-2025)

    8.4 UAE Pharmacogenomics (PGx) Market Size and Forecast (2015-2025)

    8.5 Egypt Pharmacogenomics (PGx) Market Size and Forecast (2015-2025)

    8.6 South Africa Pharmacogenomics (PGx) Market Size and Forecast (2015-2025)

9 Market Size Segment by Type

    9.1 Global Pharmacogenomics (PGx) Market Size and Forecast by Type (2015-2025)

        9.1.1 Global Pharmacogenomics (PGx) Market Size by Type (2015-2020)

        9.1.2 Global Pharmacogenomics (PGx) Market Size Forecast by Type (2020-2025)

    9.2 China Pharmacogenomics (PGx) Market Size and Forecast by Type (2015-2025)

        9.2.1 China Pharmacogenomics (PGx) Market Size by Type (2015-2020)

        9.2.2 China Pharmacogenomics (PGx) Market Size Forecast by Type (2020-2025)

10 Market Size Segment by Application

    10.1 Global Pharmacogenomics (PGx) Market Size and Forecast by Application (2015-2025)

        10.1.1 Global Pharmacogenomics (PGx) Market Size by Application (2015-2020)

        10.1.2 Global Pharmacogenomics (PGx) Market Size Forecast by Application (2020-2025)

    10.2 China Pharmacogenomics (PGx) Market Size and Forecast by Application (2015-2025)

        10.2.1 China Pharmacogenomics (PGx) Market Size by Application (2015-2020)

        10.2.2 China Pharmacogenomics (PGx) Market Size Forecast by Application (2020-2025)

11 Research Findings and Conclusion

12 Appendix

    12.1 Methodology

    12.2 Data Source

    12.3 Disclaimer

    12.4 About US

List of Tables

    Table 1. Global Pharmacogenomics (PGx) Revenue (USD Million) by Type: 2015 Versus 2019 Versus 2025

    Table 2. Breakdown of Pharmacogenomics (PGx) by Company Type (Tier 1, Tier 2 and Tier 3)

    Table 3. Global Pharmacogenomics (PGx) Revenue (USD Million) by Application: 2015 Versus 2019 Versus 2025

    Table 4. Global Market Pharmacogenomics (PGx) Market Size (USD Million) Comparison by Regions (2020-2025)

    Table 5. Global Pharmacogenomics (PGx) Revenue (USD Million) by Regions (2015-2020)

    Table 6. Global Pharmacogenomics (PGx) Revenue Share by Regions (2015-2020)

    Table 7. Global Pharmacogenomics (PGx) Revenue (USD Million) by Regions (2020-2025)

    Table 8. Global Pharmacogenomics (PGx) Revenue Market Share by Regions (2020-2025)

    Table 9. Abbott Laboratories Corporate Information, Location and Competitors

    Table 10. Abbott Laboratories Major Business

    Table 11. Abbott Laboratories Pharmacogenomics (PGx) Total Revenue (USD Million) (2017-2018)

    Table 12. Abbott Laboratories SWOT Analysis

    Table 13. Abbott Laboratories Pharmacogenomics (PGx) Product and Solutions

    Table 14. Abbott Laboratories Pharmacogenomics (PGx) Revenue (USD Million), Gross Margin and Market Share (2018-2019)

    Table 15. Myriad Genetics, Inc. Corporate Information, Location and Competitors

    Table 16. Myriad Genetics, Inc. Major Business

    Table 17. Myriad Genetics, Inc. Pharmacogenomics (PGx) Total Revenue (USD Million) (2018-2019)

    Table 18. Myriad Genetics, Inc. SWOT Analysis

    Table 19. Myriad Genetics, Inc. Pharmacogenomics (PGx) Product and Solutions

    Table 20. Myriad Genetics, Inc. Pharmacogenomics (PGx) Revenue (USD Million), Gross Margin and Market Share (2018-2019)

    Table 21. Astrazeneca Corporate Information, Location and Competitors

    Table 22. Astrazeneca Major Business

    Table 23. Astrazeneca Pharmacogenomics (PGx) Total Revenue (USD Million) (2017-2018)

    Table 24. Astrazeneca SWOT Analysis

    Table 25. Astrazeneca Pharmacogenomics (PGx) Product and Solutions

    Table 26. Astrazeneca Pharmacogenomics (PGx) Revenue (USD Million), Gross Margin and Market Share (2018-2019)

    Table 27. Affymetrix, Inc. Corporate Information, Location and Competitors

    Table 28. Affymetrix, Inc. Major Business

    Table 29. Affymetrix, Inc. Pharmacogenomics (PGx) Total Revenue (USD Million) (2017-2018)

    Table 30. Affymetrix, Inc. SWOT Analysis

    Table 31. Affymetrix, Inc. Pharmacogenomics (PGx) Product and Solutions

    Table 32. Affymetrix, Inc. Pharmacogenomics (PGx) Revenue (USD Million), Gross Margin and Market Share (2018-2019)

    Table 33. Laboratory Corporation of America Holdings Corporate Information, Location and Competitors

    Table 34. Laboratory Corporation of America Holdings Major Business

    Table 35. Laboratory Corporation of America Holdings Pharmacogenomics (PGx) Total Revenue (USD Million) (2017-2018)

    Table 36. Laboratory Corporation of America Holdings SWOT Analysis

    Table 37. Laboratory Corporation of America Holdings Pharmacogenomics (PGx) Product and Solutions

    Table 38. Laboratory Corporation of America Holdings Pharmacogenomics (PGx) Revenue (USD Million), Gross Margin and Market Share (2018-2019)

    Table 39. Assurex Health, Inc Corporate Information, Location and Competitors

    Table 40. Assurex Health, Inc Major Business

    Table 41. Assurex Health, Inc Pharmacogenomics (PGx) Total Revenue (USD Million) (2017-2018)

    Table 42. Assurex Health, Inc SWOT Analysis

    Table 43. Assurex Health, Inc Pharmacogenomics (PGx) Product and Solutions

    Table 44. Assurex Health, Inc Pharmacogenomics (PGx) Revenue (USD Million), Gross Margin and Market Share (2018-2019)

    Table 45. Pfizer, Inc Corporate Information, Location and Competitors

    Table 46. Pfizer, Inc Major Business

    Table 47. Pfizer, Inc Pharmacogenomics (PGx) Total Revenue (USD Million) (2017-2018)

    Table 48. Pfizer, Inc SWOT Analysis

    Table 49. Pfizer, Inc Pharmacogenomics (PGx) Product and Solutions

    Table 50. Pfizer, Inc Pharmacogenomics (PGx) Revenue (USD Million), Gross Margin and Market Share (2018-2019)

    Table 51. Illumina, Inc. Corporate Information, Location and Competitors

    Table 52. Illumina, Inc. Major Business

    Table 53. Illumina, Inc. Pharmacogenomics (PGx) Total Revenue (USD Million) (2017-2018)

    Table 54. Illumina, Inc. SWOT Analysis

    Table 55. Illumina, Inc. Pharmacogenomics (PGx) Product and Solutions

    Table 56. Illumina, Inc. Pharmacogenomics (PGx) Revenue (USD Million), Gross Margin and Market Share (2018-2019)

    Table 57. GeneDX Corporate Information, Location and Competitors

    Table 58. GeneDX Major Business

    Table 59. GeneDX Pharmacogenomics (PGx) Total Revenue (USD Million) (2017-2018)

    Table 60. GeneDX SWOT Analysis

    Table 61. GeneDX Pharmacogenomics (PGx) Product and Solutions

    Table 62. GeneDX Pharmacogenomics (PGx) Revenue (USD Million), Gross Margin and Market Share (2018-2019)

    Table 63. Pathway Genomics Corporate Information, Location and Competitors

    Table 64. Pathway Genomics Major Business

    Table 65. Pathway Genomics Pharmacogenomics (PGx) Total Revenue (USD Million) (2017-2018)

    Table 66. Pathway Genomics SWOT Analysis

    Table 67. Pathway Genomics Pharmacogenomics (PGx) Product and Solutions

    Table 68. Pathway Genomics Pharmacogenomics (PGx) Revenue (USD Million), Gross Margin and Market Share (2018-2019)

    Table 69. Transgenomic, Inc. Corporate Information, Location and Competitors

    Table 70. Transgenomic, Inc. Major Business

    Table 71. Transgenomic, Inc. Pharmacogenomics (PGx) Total Revenue (USD Million) (2017-2018)

    Table 72. Transgenomic, Inc. SWOT Analysis

    Table 73. Transgenomic, Inc. Pharmacogenomics (PGx) Product and Solutions

    Table 74. Transgenomic, Inc. Pharmacogenomics (PGx) Revenue (USD Million), Gross Margin and Market Share (2018-2019)

    Table 75. Qiagen, Inc. Corporate Information, Location and Competitors

    Table 76. Qiagen, Inc. Major Business

    Table 77. Qiagen, Inc. Pharmacogenomics (PGx) Total Revenue (USD Million) (2017-2018)

    Table 78. Qiagen, Inc. SWOT Analysis

    Table 79. Qiagen, Inc. Pharmacogenomics (PGx) Product and Solutions

    Table 80. Qiagen, Inc. Pharmacogenomics (PGx) Revenue (USD Million), Gross Margin and Market Share (2018-2019)

    Table 81. Thermo Fisher Scientific Corporate Information, Location and Competitors

    Table 82. Thermo Fisher Scientific Major Business

    Table 83. Thermo Fisher Scientific Pharmacogenomics (PGx) Total Revenue (USD Million) (2017-2018)

    Table 84. Thermo Fisher Scientific SWOT Analysis

    Table 85. Thermo Fisher Scientific Pharmacogenomics (PGx) Product and Solutions

    Table 86. Thermo Fisher Scientific Pharmacogenomics (PGx) Revenue (USD Million), Gross Margin and Market Share (2018-2019)

    Table 87. Rocheg Corporate Information, Location and Competitors

    Table 88. Rocheg Major Business

    Table 89. Rocheg Pharmacogenomics (PGx) Total Revenue (USD Million) (2017-2018)

    Table 90. Rocheg SWOT Analysis

    Table 91. Rocheg Pharmacogenomics (PGx) Product and Solutions

    Table 92. Rocheg Pharmacogenomics (PGx) Revenue (USD Million), Gross Margin and Market Share (2018-2019)

    Table 93. Teva Pharmaceutical Industries Ltd. Corporate Information, Location and Competitors

    Table 94. Teva Pharmaceutical Industries Ltd. Major Business

    Table 95. Teva Pharmaceutical Industries Ltd. Pharmacogenomics (PGx) Total Revenue (USD Million) (2017-2018)

    Table 96. Teva Pharmaceutical Industries Ltd. SWOT Analysis

    Table 97. Teva Pharmaceutical Industries Ltd. Pharmacogenomics (PGx) Product and Solutions

    Table 98. Teva Pharmaceutical Industries Ltd. Pharmacogenomics (PGx) Revenue (USD Million), Gross Margin and Market Share (2018-2019)

    Table 99. Global Pharmacogenomics (PGx) Revenue (USD Million) by Players (2015-2020)

    Table 100. Global Pharmacogenomics (PGx) Revenue Share by Players (2015-2020)

    Table 101. Key Players Pharmacogenomics (PGx) Revenue (USD Million) in China (2015-2020)

    Table 102. Key Players Pharmacogenomics (PGx) Revenue Share in China (2015-2020)

    Table 103. North America Pharmacogenomics (PGx) Revenue (USD Million) by Countries (2015-2020)

    Table 104. North America Pharmacogenomics (PGx) Revenue Market Share by Countries (2015-2020)

    Table 105. North America Pharmacogenomics (PGx) Revenue (USD Million) by Countries (2020-2026)

    Table 106. North America Pharmacogenomics (PGx) Revenue Market Share by Countries (2020-2026)

    Table 107. Europe Pharmacogenomics (PGx) Revenue (USD Million) by Countries (2015-2020)

    Table 108. Europe Pharmacogenomics (PGx) Revenue Market Share by Countries (2015-2020)

    Table 109. Europe Pharmacogenomics (PGx) Revenue (USD Million) by Countries (2020-2026)

    Table 110. Europe Pharmacogenomics (PGx) Revenue Market Share by Countries (2020-2026)

    Table 111. Asia-Pacific Pharmacogenomics (PGx) Revenue (USD Million) by Countries (2015-2020)

    Table 112. Asia-Pacific Pharmacogenomics (PGx) Revenue Market Share by Countries (2015-2020)

    Table 113. Asia-Pacific Pharmacogenomics (PGx) Revenue (USD Million) by Countries (2020-2026)

    Table 114. Asia-Pacific Pharmacogenomics (PGx) Revenue Market Share by Countries (2020-2026)

    Table 115. South America Pharmacogenomics (PGx) Revenue (USD Million) by Countries (2015-2020)

    Table 116. South America Pharmacogenomics (PGx) Revenue Market Share by Countries (2015-2020)

    Table 117. South America Pharmacogenomics (PGx) Revenue (USD Million) by Countries (2020-2026)

    Table 118. South America Pharmacogenomics (PGx) Revenue Market Share by Countries (2020-2026)

    Table 119. Middle East & Africa Pharmacogenomics (PGx) Revenue (USD Million) by Countries (2015-2020)

    Table 120. Middle East & Africa Pharmacogenomics (PGx) Revenue Market Share by Countries (2015-2020)

    Table 121. Middle East & Africa Pharmacogenomics (PGx) Revenue (USD Million) by Countries (2020-2026)

    Table 122. Middle East & Africa Pharmacogenomics (PGx) Revenue Market Share by Countries (2020-2026)

    Table 123. Global Pharmacogenomics (PGx) Revenue (USD Million) by Type (2015-2020)

    Table 124. Global Pharmacogenomics (PGx) Revenue Share by Type (2015-2020)

    Table 125. Global Pharmacogenomics (PGx) Revenue Forecast by Type (2020-2025)

    Table 126. Global Pharmacogenomics (PGx) Market Share Forecast by Type (2020-2025)

    Table 127. China Pharmacogenomics (PGx) Revenue (USD Million) by Type (2015-2020)

    Table 128. China Pharmacogenomics (PGx) Revenue Share by Type (2015-2020)

    Table 129. China Pharmacogenomics (PGx) Revenue Forecast by Type (2020-2025)

    Table 130. China Pharmacogenomics (PGx) Market Share Forecast by Type (2020-2025)

    Table 131. Global Pharmacogenomics (PGx) Revenue (USD Million) by Application (2015-2020)

    Table 132. Global Pharmacogenomics (PGx) Revenue Share by Application (2015-2020)

    Table 133. Global Pharmacogenomics (PGx) Revenue Forecast by Application (2020-2025)

    Table 134. Global Pharmacogenomics (PGx) Market Share Forecast by Application (2020-2025)

    Table 135. China Pharmacogenomics (PGx) Revenue (USD Million) by Application (2015-2020)

    Table 136. China Pharmacogenomics (PGx) Revenue Share by Application (2015-2020)

    Table 137. China Pharmacogenomics (PGx) Revenue Forecast by Application (2020-2025)

    Table 138. China Pharmacogenomics (PGx) Market Share Forecast by Application (2020-2025)

List of Figures

    Figure 1. Pharmacogenomics (PGx) Picture

    Figure 2. Global Pharmacogenomics (PGx) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

    Figure 3. Global Pharmacogenomics (PGx) Revenue Market Share by Type in 2019

    Figure 4. Polymerase Chain Reaction (PCR) Picture

    Figure 5. Microarray Picture

    Figure 6. Sequencing Picture

    Figure 7. Other Picture

    Figure 8. Pharmacogenomics (PGx) Revenue Market Share by Application in 2019

    Figure 9. Cardiovascular Diseases (CVD) Picture

    Figure 10. Central Nervous System (CNS) Picture

    Figure 11. Cancer/Oncology Picture

    Figure 12. Infectious Diseases Picture

    Figure 13. Other Picture

    Figure 14. Global Pharmacogenomics (PGx) Revenue and Growth Rate (2015-2025) (USD Million)

    Figure 15. Global Pharmacogenomics (PGx) Market Size Share by Regions (2015-2025)

    Figure 16. Global Pharmacogenomics (PGx) Market Size Share by Regions in 2019

    Figure 17. Global Pharmacogenomics (PGx) Revenue Market Share by Regions (2020-2025)

    Figure 18. North America Pharmacogenomics (PGx) Revenue (USD Million) and Growth Rate (2015-2025)

    Figure 19. Europe Pharmacogenomics (PGx) Revenue (USD Million) and Growth Rate (2015-2025)

    Figure 20. Asia-Pacific Pharmacogenomics (PGx) Revenue (USD Million) and Growth Rate (2015-2025)

    Figure 21. South America Pharmacogenomics (PGx) Revenue (USD Million) and Growth Rate (2015-2025)

    Figure 22. Middle East & Africa Pharmacogenomics (PGx) Revenue (USD Million) and Growth Rate (2015-2025)

    Figure 23. Global Pharmacogenomics (PGx) Revenue Share by Players in 2019

    Figure 24. Global Top 5 Players Pharmacogenomics (PGx) Revenue Market Share in 2019

    Figure 25. Top 10 Players Pharmacogenomics (PGx) Revenue Market Share in Global Market in 2019

    Figure 26. Global Pharmacogenomics (PGx) Market Size (USD Million) by Type (2015-2025)

    Figure 27. Global Pharmacogenomics (PGx) Market Size Share by Application (2015-2025)

    Figure 28. North America Pharmacogenomics (PGx) Market Size Share by Countries (2015-2025)

    Figure 29. North America Pharmacogenomics (PGx) Market Size Share by Countries in 2019

    Figure 30. United States Pharmacogenomics (PGx) Market Size (USD Million) and Forecast (2015-2025)

    Figure 31. Canada Pharmacogenomics (PGx) Market Size (USD Million) and Forecast (2015-2025)

    Figure 32. Mexico Pharmacogenomics (PGx) Market Size (USD Million) and Forecast (2015-2025)

    Figure 33. Europe Pharmacogenomics (PGx) Market Size Share by Countries (2015-2025)

    Figure 34. Europe Pharmacogenomics (PGx) Market Size Share by Countries in 2019

    Figure 35. Germany Pharmacogenomics (PGx) Market Size (USD Million) and Forecast (2015-2025)

    Figure 36. France Pharmacogenomics (PGx) Market Size (USD Million) and Forecast (2015-2025)

    Figure 37. Russia Pharmacogenomics (PGx) Market Size (USD Million) and Forecast (2015-2025)

    Figure 38. Italy Pharmacogenomics (PGx) Market Size (USD Million) and Forecast (2015-2025)

    Figure 39. Spain Pharmacogenomics (PGx) Market Size (USD Million) and Forecast (2015-2025)

    Figure 40. UK Pharmacogenomics (PGx) Market Size (USD Million) and Forecast (2015-2025)

    Figure 41. Asia Pharmacogenomics (PGx) Market Size Share by Countries (2015-2025)

    Figure 42. Asia Pharmacogenomics (PGx) Market Size Share by Countries in 2019

    Figure 43. China Pharmacogenomics (PGx) Market Size (USD Million) and Forecast (2015-2025)

    Figure 44. Japan Pharmacogenomics (PGx) Market Size (USD Million) and Forecast (2015-2025)

    Figure 45. Korea Pharmacogenomics (PGx) Market Size (USD Million) and Forecast (2015-2025)

    Figure 46. India Pharmacogenomics (PGx) Market Size (USD Million) and Forecast (2015-2025)

    Figure 47. Southeast Asia Pharmacogenomics (PGx) Market Size (USD Million) and Forecast (2015-2025)

    Figure 48. South America Pharmacogenomics (PGx) Market Size Share by Countries (2015-2025)

    Figure 49. South America Pharmacogenomics (PGx) Market Size Share by Countries in 2019

    Figure 50. Brazil Pharmacogenomics (PGx) Market Size (USD Million) and Forecast (2015-2025)

    Figure 51. Argentina Pharmacogenomics (PGx) Market Size (USD Million) and Forecast (2015-2025)

    Figure 52. Middle East & Africa Pharmacogenomics (PGx) Market Size Share by Countries (2015-2025)

    Figure 53. Middle East & Africa Pharmacogenomics (PGx) Market Size Share by Countries in 2019

    Figure 54. Saudi Arabia Pharmacogenomics (PGx) Market Size (USD Million) and Forecast (2015-2025)

    Figure 55. UAE Pharmacogenomics (PGx) Market Size (USD Million) and Forecast (2015-2025)

    Figure 56. Egypt Pharmacogenomics (PGx) Market Size (USD Million) and Forecast (2015-2025)

    Figure 57. South Africa Pharmacogenomics (PGx) Market Size (USD Million) and Forecast (2015-2025)

    Figure 58. Global Pharmacogenomics (PGx) Revenue Share by Type (2015-2020)

    Figure 59. China Pharmacogenomics (PGx) Revenue Share by Type (2015-2020)

    Figure 60. Global Pharmacogenomics (PGx) Revenue Share by Application (2015-2020)

    Figure 61. China Pharmacogenomics (PGx) Revenue Share by Application (2015-2020)

Our Clients